Tirzepatide is a novel medication cleared for treating diabetes type 2 and obesity in patients. This treatment works by simulating the actions of bodily hormones, in essence GIP and GLP-1, to improve glucose levels and encourage satiety resulting in weight decrease. Expected advantages include notable gains in glycemic control, decreased likelihood